Eric V. Li

1.5k total citations
33 papers, 482 citations indexed

About

Eric V. Li is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Oncology. According to data from OpenAlex, Eric V. Li has authored 33 papers receiving a total of 482 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Pulmonary and Respiratory Medicine, 8 papers in Molecular Biology and 5 papers in Oncology. Recurrent topics in Eric V. Li's work include Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Hormonal and reproductive studies (4 papers). Eric V. Li is often cited by papers focused on Prostate Cancer Treatment and Research (19 papers), Prostate Cancer Diagnosis and Treatment (17 papers) and Hormonal and reproductive studies (4 papers). Eric V. Li collaborates with scholars based in United States, Netherlands and Norway. Eric V. Li's co-authors include Edward M. Schaeffer, Abigail F. Groff, Lara E. Elcavage, Martin Sauvageau, Adam B. Weiner, Chiara Gerhardinger, Olivia D. Plana, John L. Rinn, Ryan Martin and Paola Arlotta and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Cancer and Scientific Reports.

In The Last Decade

Eric V. Li

26 papers receiving 482 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eric V. Li United States 10 241 216 98 45 42 33 482
Christophe Carré France 6 277 1.1× 87 0.4× 32 0.3× 42 0.9× 88 2.1× 8 663
Giuseppe Biscaglia Italy 15 252 1.0× 156 0.7× 67 0.7× 155 3.4× 111 2.6× 37 681
Yubo Zhao China 11 196 0.8× 111 0.5× 46 0.5× 14 0.3× 37 0.9× 29 407
Aristeidis Chrysovergis Greece 10 122 0.5× 45 0.2× 41 0.4× 12 0.3× 64 1.5× 50 360
David F. Jenkins United States 11 93 0.4× 41 0.2× 43 0.4× 32 0.7× 39 0.9× 20 306
Hongli Liu China 14 142 0.6× 84 0.4× 36 0.4× 52 1.2× 102 2.4× 49 478
Kao-Jung Chang Taiwan 11 144 0.6× 21 0.1× 32 0.3× 33 0.7× 27 0.6× 23 486
Katharina Schwarze Germany 3 162 0.7× 129 0.6× 55 0.6× 243 5.4× 35 0.8× 8 501
Yujuan Qi China 12 188 0.8× 82 0.4× 54 0.6× 47 1.0× 56 1.3× 47 395
Xue Jiang China 10 182 0.8× 94 0.4× 112 1.1× 9 0.2× 43 1.0× 30 370

Countries citing papers authored by Eric V. Li

Since Specialization
Citations

This map shows the geographic impact of Eric V. Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric V. Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric V. Li more than expected).

Fields of papers citing papers by Eric V. Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric V. Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric V. Li. The network helps show where Eric V. Li may publish in the future.

Co-authorship network of co-authors of Eric V. Li

This figure shows the co-authorship network connecting the top 25 collaborators of Eric V. Li. A scholar is included among the top collaborators of Eric V. Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eric V. Li. Eric V. Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Eric V., Edward M. Schaeffer, Ruoji Zhou, et al.. (2025). Utility of 18F-DCFPyL PET for local staging for high or very high risk prostate cancer for patients undergoing radical prostatectomy. European Journal of Nuclear Medicine and Molecular Imaging. 52(7). 2335–2342. 2 indexed citations
3.
Li, Eric V., Mohammad R. Siddiqui, Zequn Sun, et al.. (2025). Prostate MRI and clinicopathologic risk calculator to predict laterality of extraprostatic extension at radical prostatectomy. Prostate Cancer and Prostatic Diseases. 28(4). 859–864. 1 indexed citations
4.
Ji, Ruiping, Uma Mahesh R. Avula, Andrew M. Fang, et al.. (2025). Atrial fibrillation–induced neurocognitive and vascular dysfunction is averted by mitochondrial oxidative stress reduction. JCI Insight. 10(22).
5.
Li, Eric V., J. Proudfoot, Adam B. Weiner, et al.. (2025). Prevalence of Potential Candidates for Targeted Therapies According to Treatment-related Transcriptomic Signatures Among 140 548 Patients with Nonmetastatic Prostate Cancer. European Urology Oncology. 8(4). 1050–1058. 1 indexed citations
6.
Li, Eric V., Richard G. Bennett, Chalairat Suk‐Ouichai, et al.. (2024). Testosterone recovery after androgen deprivation therapy. Urologic Oncology Seminars and Original Investigations. 43(1). 65.e1–65.e8. 1 indexed citations
7.
Patel, Hiten D., Sebastiaan Remmers, Eric V. Li, et al.. (2024). Comparison of Magnetic Resonance Imaging–Based Risk Calculators to Predict Prostate Cancer Risk. JAMA Network Open. 7(3). e241516–e241516. 8 indexed citations
8.
Li, Eric V., Mohammad R. Siddiqui, Xinlei Mi, et al.. (2024). Detection of clinically significant prostate cancer following initial omission of biopsy in multiparametric MRI era. Prostate Cancer and Prostatic Diseases. 28(3). 795–801. 2 indexed citations
9.
Bennett, R. C., Eric V. Li, Steven P. Rowe, et al.. (2024). Implementation of PSMA PET/CT and alignment of ordering to SNMMI appropriate use criteria in a large network system. The Prostate. 84(8). 717–722. 1 indexed citations
10.
Li, Eric V., R. C. Bennett, Yutai Li, et al.. (2024). Ultrasensitive PSA: rethinking post-surgical management for node positive prostate cancer. Frontiers in Oncology. 14. 1363009–1363009.
11.
Bennett, R. C., Eric V. Li, Chalairat Suk‐Ouichai, et al.. (2024). Contemporary Diagnosis of Very Low-risk Prostate Cancer in a Multihospital Health Care System. European Urology Oncology. 7(6). 1179–1182.
12.
Li, Eric V., Mohammad R. Siddiqui, Edward M. Schaeffer, et al.. (2023). Utilization of genetic testing in men with advanced prostate cancer. The Prostate. 83(6). 516–523. 7 indexed citations
13.
Siddiqui, Mohammad R., Eric V. Li, Parth Shah, et al.. (2023). Optimizing detection of clinically significant prostate cancer through nomograms incorporating mri, clinical features, and advanced serum biomarkers in biopsy naïve men. Prostate Cancer and Prostatic Diseases. 26(3). 588–595. 15 indexed citations
14.
Li, Eric V., et al.. (2023). Developing a disease-specific annotation protocol for VHL gene curation using Hypothes.is. Database. 2023. 1 indexed citations
15.
Siddiqui, Mohammad R., Parth Shah, Eric V. Li, et al.. (2022). Real-world use of MRI for risk stratification prior to prostate biopsy. Prostate Cancer and Prostatic Diseases. 26(2). 353–359. 18 indexed citations
16.
Weiner, Adam B., Yang Liu, Matthew McFarlane, et al.. (2021). A transcriptomic model for homologous recombination deficiency in prostate cancer. Prostate Cancer and Prostatic Diseases. 25(4). 659–665. 10 indexed citations
17.
Weiner, Adam B., et al.. (2021). Cause of death during prostate cancer survivorship: A contemporary, US population–based analysis. Cancer. 127(16). 2895–2904. 40 indexed citations
18.
Weiner, Adam B., et al.. (2020). Survival following upfront chemotherapy for treatment-naïve metastatic prostate cancer: a real-world retrospective cohort study. Prostate Cancer and Prostatic Diseases. 24(1). 261–267. 6 indexed citations
19.
Weiner, Adam B., William J. Catàlona, Eric V. Li, et al.. (2018). Inflammatory Bowel Disease and the Risk of Prostate Cancer. European Urology. 75(5). 846–852. 46 indexed citations
20.
Groff, Abigail F., Chiara Gerhardinger, A. Rasim Barutcu, et al.. (2016). In Vivo Characterization of Linc-p21 Reveals Functional cis-Regulatory DNA Elements. Cell Reports. 16(8). 2178–2186. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Christophe Carré Breakdown of academic impact, for papers by Giuseppe Biscaglia Breakdown of academic impact, for papers by Yubo Zhao Breakdown of academic impact, for papers by Aristeidis Chrysovergis Breakdown of academic impact, for papers by David F. Jenkins Breakdown of academic impact, for papers by Hongli Liu Breakdown of academic impact, for papers by Kao-Jung Chang Breakdown of academic impact, for papers by Katharina Schwarze Breakdown of academic impact, for papers by Yujuan Qi Breakdown of academic impact, for papers by Xue Jiang
Rankless by CCL
2026